𝔖 Bobbio Scriptorium

✦ LIBER ✦

Preoperative 3-Tesla Multiparametric Endorectal MRI Findings and the Odds of Upgrading and Upstaging at Radical Prostatectomy in Men With Clinically Localized Prostate Cancer

✍ Scribed by Hegde, J.; Chen, M.; Mulkern, R.V.; Fennessy, F.M.; Tempany, C.M.; D'Amico, A.V.

Book ID: 123451757
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 79 KB
Volume: 84
Category: Article
ISSN: 0360-3016
DOI: 10.1016/j.ijrobp.2012.07.949

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Preoperative 3-Tesla Multiparametric End

Preoperative 3-Tesla Multiparametric Endorectal Magnetic Resonance Imaging Findings and the Odds of Upgrading and Upstaging at Radical Prostatectomy in Men With Clinically Localized Prostate Cancer

✍ Hegde, John V.; Chen, Ming-Hui; Mulkern, Robert V.; Fennessy, Fiona M.; D'Amico, 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 172 KB

Health-insurance status is a determinant

Health-insurance status is a determinant of the stage at presentation and of cancer control in European men treated with radical prostatectomy for clinically localized prostate cancer

✍ Andrea Gallina; Pierre I. Karakiewicz; Felix K.-H. Chun; Alberto Briganti; Marku 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 177 KB

Can multiparametric magnetic resonance i

Can multiparametric magnetic resonance imaging predict upgrading of transrectal ultrasound biopsy results at more definitive histology?11Mohamed Abd-Alazeez receives funding from the Egyptian government. Mark Emberton and Hashim U. Ahmed receive funding from USHIFU and Advanced Medical Diagnostics for clinical trials. Mark Emberton is a paid consultant for Steba Biotech, USHIFU and Sanofi-Aventis. Mark Emberton has received research support by GSK for a study evaluating the role of MRI in men with prostate cancer. Mark Emberton and Hashim Ahmed have previously received medical consultancy fees from GE Healthcare/Oncura and Hashim Ahmed previously from Steba Biotech. Mark Emberton is a medical director of Mediwatch PLC. Hashim Uddin Ahmed and Mark Emberton receive funding from the Medical Research Council, the NIHR-HTA, NIHR-i4i, the US NIH/NCI, Pelican Cancer Foundation, Prostate Cancer UK, and St Peter׳s Trust. This work was part funded by research support for Mark Emberton and Alex Kirkham from the UK National Institute of Health Research UCLH/UCL Comprehensive Biomedical Research Centre, London, UK.

✍ Abd-Alazeez, Mohamed; Ahmed, Hashim U.; Arya, Manit; Allen, Clare; Dikaios, Niko 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 415 KB